Refinitiv Newscasts - Asia Insight: Nikkei hits 30-year high as drug makers rally on COVID-19 news
12/01/2021 08:30
Click the following link to watch video: https://share.newscasts.refinitiv.com/link?entryId=1_ptybpjle&referenceId=1_ptybpjle&pageId=RefinitivNewscasts Source: Reuters Description: Japan's benchmark Nikkei share average inched up to close at a fresh three-decade high. Drugmakers led the buying on a report that Chugai Pharmaceutical's drug was effective in treating COVID-19 patients. Short Link: https://refini.tv/3nC9EI7 Video Transcript: Verified transcript not available
Recent news on Chugai Pharmaceutical
See all newsRegarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For SMA
Table: Chugai Pharm 6-MTH group results (IFRS)
Japan's Nikkei roars past 62,000 on earnings, Middle East optimism; JGBs rally (updated)
Japan's Nikkei surges past 61,000 for first time on earnings, Mideast optimism
Japan's Nikkei closes above 60,000 for first time on earnings optimism (updated)